FGF1 and diabetes mellitus: Although FGF1 has antidiabetic effects, the tumorigenic risks associated with chronic FGF1 administration have raised concerns about its use as a pharmacotherapy for diabetes (Jiao et al., 2015; Kwabi-Addo et al., 2004).